Annakan V Navaratnam
Overview
Explore the profile of Annakan V Navaratnam including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
216
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Williams I, Rotimi O, Burrows L, Navaratnam A, Tan N
Int Forum Allergy Rhinol
. 2025 Feb;
15(3):317-327.
PMID: 39968608
Objectives: Paediatric sinonasal disease is prevalent worldwide, giving rise to substantial healthcare costs and morbidity. However, there is a lack of sinus-specific patient-reported outcome measures (PROMs) tailored for children. This...
2.
Williams I, Chin Liu M, Navaratnam A, Ferguson M
J Laryngol Otol
. 2024 Apr;
138(9):902-905.
PMID: 38623846
Objective: Nasal septoplasty is one of the most performed procedures within ENT. Nasal obstruction secondary to a deviated nasal septum is the primary indication for functional septoplasty. Since the coronavirus...
3.
Pendolino A, Ottaviano G, Navaratnam A, Scarpa B, Andrews P
Laryngoscope Investig Otolaryngol
. 2023 Dec;
8(6):1449-1458.
PMID: 38130252
Objectives: Factors affecting persistence of COVID-19-related olfactory dysfunction (OD) remain partially unknown. We aim to evaluate the clinical factors which could influence olfactory performance in patients with persistent COVID-19-related smell...
4.
Pendolino A, Benshetrit G, Navaratnam A, To C, Bandino F, Scarpa B, et al.
Laryngoscope
. 2023 Dec;
134(6):2609-2616.
PMID: 38084793
Objective: In this multicentric study involving three London hospitals, we compared ANCA-positive and ANCA-negative cocaine-induced midline destructive lesions (CIMDL) patients to assess how presence of antineutrophil cytoplasmic antibodies (ANCA) may...
5.
6.
Williams I, Navaratnam A, Wilson M, Ferguson M
Case Rep Otolaryngol
. 2023 Oct;
2023:6996215.
PMID: 37841560
Eighty percent of cerebrospinal fluid leaks (CSF) occur following trauma and complicate 12 to 13% percent of all basilar skull fractures (Prosser, Vender, and Solares, 2011). An endoscopic endonasal approach...
7.
Gray W, Navaratnam A, Day J, Heyl J, Hardy F, Wheeler A, et al.
Emerg Med J
. 2023 May;
40(8):542-548.
PMID: 37236779
Background: In England, reported COVID-19 mortality rates increased during winter 2020/21 relative to earlier summer and autumn months. This study aimed to examine the association between COVID-19-related hospital bed-strain during...
8.
Gray W, Navaratnam A, Rennie C, Mendoza N, Briggs T, Phillips N
Br J Neurosurg
. 2023 Feb;
39(1):44-51.
PMID: 36740733
Background: Setting minimum annual volume thresholds for pituitary surgery in England is seen as one way of improving outcomes for patients and service efficiency. However, there are few recent studies...
9.
Heyl J, Hardy F, Tucker K, Hopper A, Marcha M, Navaratnam A, et al.
Interact J Med Res
. 2022 Nov;
11(2):e41520.
PMID: 36423306
Background: Older adults have worse outcomes following hospitalization with COVID-19, but within this group there is substantial variation. Although frailty and comorbidity are key determinants of mortality, it is less...
10.
Navaratnam A, Pendolino A, Andrews P, Saleh H, Hopkins C, Randhawa P, et al.
Clin Otolaryngol
. 2022 Nov;
48(2):191-199.
PMID: 36367082
Introduction: As elective surgical services recover from the COVID-19 pandemic a movement towards day-case surgery may reduce waiting lists. However, evidence is needed to show that day-case surgery is safe...